Axonics (MEX:AXNX) Accounts Payable & Accrued Expense : MXN556 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Axonics Accounts Payable & Accrued Expense?

Axonics's quarterly accounts payable & accrued expense increased from Dec. 2023 (MXN492 Mil) to Mar. 2024 (MXN507 Mil) and increased from Mar. 2024 (MXN507 Mil) to Jun. 2024 (MXN556 Mil).

Axonics's annual accounts payable & accrued expense increased from Dec. 2021 (MXN269 Mil) to Dec. 2022 (MXN304 Mil) and increased from Dec. 2022 (MXN304 Mil) to Dec. 2023 (MXN492 Mil).

Axonics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Axonics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Accounts Payable & Accrued Expense Chart

Axonics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

151.94

345.01

268.51

303.94

491.90

Axonics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															304.41	359.32	491.90	506.55	556.16

Axonics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Axonics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

AXNX:USA

Address

26 Technology Drive, Irvine, CA, USA, 92618

Website

https://www.axonics.com

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.